Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02131064
Brief Title: A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

First Submitted : May 2, 2014
First Submitted that Met QC Criteria : May 2, 2014
First Posted : May 6, 2014 (Estimate)

Results First Submitted : December 3, 2016
Results First Submitted that Met QC Criteria : May 9, 2017
Results First Posted : June 8, 2017

Last Update Submitted that Met QC Criteria : September 20, 2018
Last Update Posted : October 18, 2018